dc.contributor.author | Meurer, Linda N. | eng |
dc.contributor.author | Jamieson, Barbara | eng |
dc.date.issued | 2005 | eng |
dc.description.abstract | The international normalized ratio (INR) should be measured monthly once therapeutic levels are achieved and are stable for at least 8 weeks, although treatment should be individualized and an increased frequency may be required by some patients (strength of recommendation [SOR]: C, consensus statements). For highly compliant patients with stable levels and a clear understanding of factors that influence anticoagulation (changes in health, diet, medications), routine monitoring may be extended to 6 weeks (SOR: B, single randomized controlled trial [RCT]) or longer (SOR: C, case series). Patient-managed warfarin therapy, using biweekly self-measurements, results in more time in therapeutic range than routine physicianmanaged care (SOR: A, RCTs). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3373 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2005 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 54, no. 02 (February 2005): 171+. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | international normalized ratio (INR) | eng |
dc.subject | complications | eng |
dc.subject | anticoagulation | eng |
dc.subject.lcsh | Warfarin | eng |
dc.subject.lcsh | Anticoagulants | eng |
dc.title | What is the interval for monitoring warfarin therapy once therapeutic levels are achieved? | eng |
dc.type | Article | eng |